What are the keys to pharma success in emerging markets?

04/8/2013 | Medical Marketing & Media

Strategies that have worked in mature markets will not necessarily bring success in emerging markets, according to a Booz & Co. survey of executives from more than 25 brand-name and generic-drug-makers. In Brazil, Russia, India, China, Mexico and Turkey an emphasis on local research and development opens doors, while relationships with government entities are key in so-called second-tier markets. In Africa, where the need for drugs to treat communicable diseases is stronger than the need for lifestyle drugs, relationships with distributors and nongovernmental organizations can help drugmakers overcome a weak health infrastructure, the survey found.

View Full Article in:

Medical Marketing & Media

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Project Manager RA - 15000003MD
Santa Clara, CA
Director, Site Quality Management
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC